Disclosures for "Characteristics of Carpal Tunnel Syndrome in Wild-Type Transthyretin Amyloidosis")
-
Dr. Russell has nothing to disclose.
-
Dr. Khayambashi has nothing to disclose.
-
Nowell Fine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the American College of Cardiology: Case Reports. The institution of Nowell Fine has received research support from Pfizer, Akcea.
-
The institution of Dr. Chhibber has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Chhibber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
-
Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anylim.